J. Robertson

发表

Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohort

Christopher Fowler, Paul Maruff, Colin L. Masters, 2017, Alzheimer's & Dementia.

Avoiding methodological bias in studies of amyloid imaging results disclosure

Joanne S. Robertson, C. Taswell, C. Rowe, 2019, Alzheimer's Research & Therapy.

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, GeroScience.

Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer’s Disease

Joanne S. Robertson, C. Rowe, C. Masters, 2022, Journal of Alzheimer's disease : JAD.

Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET study

Joanne S. Robertson, C. Rowe, C. Masters, 2022, medRxiv.

Embedding a Recovery Orientation into Neuroscience Research: Involving People with a Lived Experience in Research Activity

Joanne S. Robertson, P. Corlett, L. Davidson, 2016, Psychiatric quarterly.

Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer’s disease

Blaine R. Roberts, Denise C. Park, Joanne S. Robertson, 2020, Nature Communications.

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease

Joanne S. Robertson, C. Rowe, R. Martins, 2021, Journal of Alzheimer's disease reports.

Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals

Joanne S. Robertson, C. Rowe, R. Martins, 2020, Neurology.

Relationship Between Amyloid-Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults

Joanne S. Robertson, C. Rowe, C. Masters, 2018 .

Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.

Joanne S. Robertson, P. Snyder, C. Rowe, 2018, Journal of Alzheimer's disease : JAD.

The effect of preclinical Alzheimer's disease on age-related changes in intelligence in cognitively normal older adults

Joanne S. Robertson, C. Rowe, C. Masters, 2018, Intelligence.

Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease

Joanne S. Robertson, C. Rowe, C. Masters, 2018, Neurobiology of Aging.

Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness

Joanne S. Robertson, P. Snyder, C. Rowe, 2017, Alzheimer's & dementia.

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

Paul Maruff, Colin L. Masters, Greg Savage, 2013, International Psychogeriatrics.

Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture

Blaine R. Roberts, Joanne S. Robertson, R. Marioni, 2020, Nature Communications.

Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI

David A. Rolls, Joanne S. Robertson, D. Rolls, 2021, Scientific Reports.

Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer’s Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment

Joanne S. Robertson, C. Rowe, R. Martins, 2020, Journal of the International Neuropsychological Society.

Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging

Joanne S. Robertson, C. Masters, P. Maruff, 2017, Archives of Clinical Neuropsychology.

Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

Joanne S. Robertson, C. Rowe, R. Martins, 2015, Journal of Alzheimer's disease : JAD.

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

Blaine R. Roberts, Joanne S. Robertson, C. Rowe, 2014, Alzheimer's & Dementia.

Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β–negative cognitively normal individuals

Joanne S. Robertson, C. Rowe, G. Savage, 2020, Neurobiology of Aging.

APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.

Joanne S. Robertson, P. Snyder, C. Rowe, 2017, Journal of Alzheimer's disease : JAD.

MIDLIFE VASCULAR RISK, APOLIPOPROTEIN E-E4, AND AMYLOID STATUS 20 YEARS LATER: RESULTS FROM THE WOMEN’S HEALTHY AGEING PROJECT

C. Rowe, L. Dennerstein, C. Szoeke, 2014, Alzheimer's & Dementia.

Safety of Disclosing Amyloid Imaging Results to MCI and AD Patients

C. Taswell, C. Rowe, C. Masters, 2017, Brainiacs Journal of Brain Imaging And Computing Sciences.

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

Blaine R. Roberts, M. Fenech, P. Thomas, 2017, Scientific Reports.

Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years

Joanne S. Robertson, C. Rowe, R. Martins, 2018, Alzheimer disease and associated disorders.

Plasma p217+tau vs NAV4694 amyloid and MK6240 tau PET across the Alzheimer continuum.

Joanne S. Robertson, C. Rowe, R. Martins, 2022, medRxiv.

Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum

Joanne S. Robertson, C. Rowe, R. Martins, 2022, Alzheimer's & dementia.

Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.

Joanne S. Robertson, C. Rowe, C. Masters, 2018, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

The Women's Healthy Ageing Project: Fertile ground for investigation of healthy participants ‘at risk’ for dementia

Joanne S. Robertson, C. Rowe, C. Masters, 2013, International review of psychiatry.

Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

D. Ames, D. Darby, Qiao-Xin Li, 2015, Journal of Alzheimer's disease : JAD.

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

P. Maruff, C. Szoeke, K. Pike, 2013, International Psychogeriatrics.

Trajectories of Irregular Word Reading Ability as a Proxy for Premorbid Intelligence in Alzheimer’s Disease, Mild Cognitive Impairment, and Healthy Aging: A Longitudinal Study

Joanne S. Robertson, C. Rowe, R. Martins, 2018, Psychological assessment.

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

P. Maruff, V. Villemagne, P. Bourgeat, 2023, The journal of prevention of Alzheimer's disease.

Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.

C. Rowe, C. Masters, P. Maruff, 2018, Journal of Alzheimer's disease : JAD.

Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans

J. Fripp, J. Robertson, S. Ahern, 2023, Journal of Alzheimer's disease : JAD.